CIK: 1950232 - Address: 555 Heritage Drive, Suite 200, Jupiter, FL 33458
10 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
6/24/25 20:29
6/23/25
LGNDLigand Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsReardon AndrewFLOCLO,SecrS-57114.080-1-232D
6/12/25 17:51
6/10/25
LGNDLigand Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsReardon AndrewFLOCLO,SecrS-57114.540-1-232D
6/2/25 20:06
5/15/25
LGNDLigand Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsReardon AndrewFLOCLO,SecrS-104104.000-1-333D
9/25/24 20:54
9/23/24
LGNDLigand Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsReardon AndrewFLOCLO,SecrM.d10552.27021023D
9/25/24 20:54
9/23/24
LGNDLigand Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsReardon AndrewFLOCLO,SecrS.d-19999.600-2-823D
8/30/24 20:56
8/28/24
LGNDLigand Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsReardon AndrewFLOCLO,SecrM.d7852.2702723D
8/30/24 20:56
8/28/24
LGNDLigand Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsReardon AndrewFLOCLO,SecrS.d-160106.390-2-623D
5/13/24 17:32
5/9/24
LGNDLigand Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsReardon AndrewFLOGC,M.d52352.270108222D
5/13/24 17:32
5/9/24
LGNDLigand Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsReardon AndrewFLOGC,S.d-83083.040-10-3122D
3/28/23 17:00
3/24/23
LGNDLigand Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsReardon AndrewCAOSee RemaS-2169.9200-216D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact